ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NFX Nuformix Plc

0.185
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.185 0.17 0.20 - 3,293 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -859k -0.0012 -1.50 1.34M
Nuformix Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NFX. The last closing price for Nuformix was 0.19p. Over the last year, Nuformix shares have traded in a share price range of 0.17p to 0.44p.

Nuformix currently has 744,309,368 shares in issue. The market capitalisation of Nuformix is £1.34 million. Nuformix has a price to earnings ratio (PE ratio) of -1.50.

Nuformix Share Discussion Threads

Showing 4101 to 4121 of 9550 messages
Chat Pages: Latest  166  165  164  163  162  161  160  159  158  157  156  155  Older
DateSubjectAuthorDiscuss
24/12/2019
09:01
Cheers soup had an inkling about that , I should have thought and checked prior to posting
gibso6767
24/12/2019
08:58
Remember that the markets are forward looking hence why the initial move higher this morning. With sufficient cash now to move towards a sustainable and growing business with new deals in the pipeline I will continue to accumulate.
galaxy enforcer
24/12/2019
08:43
Ok ... yes thanks .. clear now.
amaretto1
24/12/2019
08:33
We are in NFX H2 2020. i.e Their financial year ending 2020.Amaretto the results only cover up to end of Sept so cash in bank won't show the recent placing.
soupdragon55
24/12/2019
08:31
Sorry , I believe you're mistaken , H1 2020 ended in Sept 2019.

Results just published are for H1 2020.

'During H1 2020 the Group has completed a significant new deal .....'

cottoner
24/12/2019
08:28
H2 in 2020 starts end of March What u talking about ??
amaretto1
24/12/2019
08:25
'Going forward the Group expects an exciting H2 2020.'

'During H1 2020 the Group has completed a significant new deal, generated revenues and hit important milestones within its partnerships, with further payments expected to come in H2 2020.'

Perhaps worth highlighting that H2 2020 in the context of NFX does not start in June 2020 , but ends in March 2020.
i.e, There are only just over 3 months remaining in NFX's H2 202

cottoner
24/12/2019
08:25
Reading them a few times, Sinks in betterCash on hand, should surely include placing money.First couple of paragraphs.
amaretto1
24/12/2019
08:23
Those results are good. Shows good solid income from Ebers and sets a baseline for news moving forward.
soupdragon55
24/12/2019
08:16
Very low cash burn fully funded and Significant Progress in Lead Programmes
dm2000
24/12/2019
08:12
Not aww inspiring ... have i read wrong ??
amaretto1
24/12/2019
08:11
Those results are ?????
amaretto1
24/12/2019
08:04
Lots of positives to take from this. Very good update on the progress made on the programmes. Revenue not an issue right now whilst they progress the programmes. Literally any deal with a big pharma company on licenses and funding will re rate this.
shanur90
24/12/2019
08:03
"We have achieved significant progress during the period, both operationally and within our lead programmes," said Dan Gooding, Nuformix's CEOhTTps://www.proactiveinvestors.co.uk/companies/amp/news/909782?__twitter_impression=true
tidy 2
24/12/2019
08:03
Operationally very good update Significant Progress in Lead Programmes
shanur90
24/12/2019
08:01
Uncertain what to make of them , income of £535k over the year and £132k in the bank, no Chinese payment which to me is the financial proof of concept ie mayor constant initial payment then a constant income to keep the wolves at bay ie dilution or other to get more cash at hand .

ALTHOUGH FURTHER DOWN NO FUNDING REQUIRED TILL 2021 !

gibso6767
24/12/2019
07:58
Revenue down to £0.54m. Not what we wanted to read on Christmas Eve. Taking too long. Pharma/Bio always does. Particularly the Chinese; horrible to deal with. Justin the Clown trying to ramp these results on Twitter. :(
2prsimo
23/12/2019
19:50
Not a bad day today. Tested 8p twice. Hopefully break it tomorrow.
shanur90
23/12/2019
19:24
It's held on to fridays gains, which is a big plus.
amaretto1
23/12/2019
15:31
We will get interims this side of new year.
soupdragon55
23/12/2019
15:28
I think that like I said early I cannot envisage news this year , the few remaining days we have left , any news would be forgotten, overlooked or even massively sold into .

I’m hoping first full weeks trading for news , which apart from interims hopefully will have expected and some unknown good news , get us easily and quickly to an all time high

gibso6767
Chat Pages: Latest  166  165  164  163  162  161  160  159  158  157  156  155  Older

Your Recent History

Delayed Upgrade Clock